Premier Biotech - About the company
Premier Biotech is a late stage company based in Minneapolis (United States), founded in 2009. It operates as an Innovative drug testing solutions: rapid, reliable, customizable for diverse organizations. Premier Biotech has raised an undisclosed amount in funding from Align Capital Partners. The company has 17 active competitors, including 5 funded and 3 that have exited. Its top competitors include companies like Genomind, Assurex Health and Polaris Genomics.
Company Details
Innovative drug testing solutions: rapid, reliable, customizable for diverse organizations. They provide cutting-edge drug testing tools and services, focusing on accuracy and speed. They integrate testing, technology, and labs to offer innovative solutions, purpose-built technology integrations, and accredited lab testing. They aim to be a strategic partner, offering customizable panels, white-glove customer service, and fast turnaround times. Their offerings include rapid oral fluid and urine tests, lab confirmation services, and technology for rapid reporting. They serve various industries, including workplace, government, clinical, and forensic sectors. Their OralTox solution is a recognized name in rapid oral fluid testing. They offer training, support, and technology integrations to streamline drug testing programs and ensure compliance. They focus on innovation, research, and development to stay ahead of evolving drug trends.
- Website
- premierbiotech.com
- Phone Number
- +1 **********
- Registered Address
- Minneapolis, Minnesota
Key Metrics
Founded Year
2009
Location
Minneapolis, United States
Stage
Late Stage
Latest Funding Round
Investors
Ranked
3rd among 17 active competitors
Employee Count
95 as on Jul 31, 2026
Investment & Acquisitions
Legal entities associated with Premier Biotech
Premier Biotech is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Premier Biotech, Inc. CIN: 270962878 , United States, Active | Dec 26, 999 | - | 102 (As on Dec 31, 2020) | - |
Sign up to download Premier Biotech's company profile
Premier Biotech's funding and investors
Premier Biotech has raised funding over 1 round. Its latest funding round was a PE round on Dec 07, 2022 for $*****. 1 investor participated in its latest round. Premier Biotech has 1 institutional investor.
Here is the list of recent funding rounds of Premier Biotech:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 07, 2022 | 5513589 | PE | 5434782 | 9795587 | 4690905 | 1797798 |
View details of Premier Biotech's funding rounds and investors
Premier Biotech's founders and board of directors
Founder? Claim ProfilePremier Biotech's employee count trend
Premier Biotech has 95 employees as of Jul 26. Here is Premier Biotech's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Premier Biotech's Competitors and alternates
Top competitors of Premier Biotech include Genomind, Assurex Health and Polaris Genomics. Here is the list of Top 10 competitors of Premier Biotech, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Genomind 2009, King Of Prussia (United States), Series C | Developer of genetic tests for personalised medicines to enhance mental health treatment | $64.4M | 56/100 | |
2nd | Assurex Health 2006, Mason (United States), Acquired | Personalized neuropsychiatric medicine | $84.5M | 47/100 | |
3rd | Premier Biotech 2009, Minneapolis (United States), Late Stage | Innovative drug testing solutions: rapid, reliable, customizable for diverse organizations | - | 44/100 | |
4th | Polaris Genomics 2017, Rockville (United States), Series A | Developer genomic-based diagnostics and therapeutics for neurological conditions | $800K | 38/100 | |
5th | SensoDetect 2005, Lund (Sweden), Public | Brainstem audiometry based test for schizophrenia and ADHD | - | - | 37/100 |
6th | Developer of pharmacogenomics tools for treatment regimens using anti-depressants | $1.01M | 36/100 | ||
7th | PreciseMent 2021, Israel, Unfunded | Provider of precision medicine solutions for mental health treatment | - | - | 33/100 |
8th | BioBDx 2004, Westford (United States), Acqui-Hired | Tools for assessment of ADHD symptoms | $30.4M | 32/100 | |
9th | Neurovation Labs 2016, New York City (United States), Seed | Precision neuromedicines for mental health disorders via novel drug discovery | - | 31/100 | |
10th | Ridge Diagnostics 2006, San Diego (United States), Deadpooled | Neurodiagnostic company offering blood tests for major depressive disorder | $7.43M | 31/100 |
Looking for more details on Premier Biotech's competitors? Click here to see the top ones
Premier Biotech's Investments and acquisitions
Premier Biotech has acquired 3 companies including GH Solutions, Ntsbiz and Desert Tox. Premier Biotech has not made any investments as of now.Here is the list of its acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Apr 09, 2026 | Acquisition | |||
Nov 05, 2025 | Acquisition | - | ||
Jun 06, 2024 | Acquisition | 2017 | Scottsdale (United States) |
See all acquisitions by Premier Biotech
Reports related to Premier Biotech
Here is the latest report on Premier Biotech's sector:
News related to Premier Biotech
Media has covered Premier Biotech for a total of 2 events in the last 1 year, 1 of them has been about people movement.
•
Premier Biotech Appoints Industry Veteran Rod Weis as Chief Revenue Officer to Accelerate Market LeadershipBusiness Wire•Dec 03, 2025•Premier Biotech
•
Premier Acquires NTS to Accelerate Growth in Point-of-Care Drug Screening ServicesBusiness Wire•Nov 05, 2025•Ntsbiz, Premier Biotech
•
Acp-backed Premier Biotech Acquires Drug Testing Firm Desert ToxPE Hub•Jun 06, 2024•Premier Biotech, Desert Tox
•
•
•
First Advantage Adds New Instant Oral Fluid Drug Testing Device OralTox® to Its Suite of ProductsGlobeNewswire•Apr 18, 2018•First Advantage, Premier Biotech
•
Premier Biotech’s Oral Fluid Drug Testing Device Granted FDA ClearanceMedical Product Outsourcing•Apr 06, 2018•Premier Biotech
Are you a Founder ?
FAQs about Premier Biotech
Explore our recently published companies
- Captain - Montreal based, 2021 founded, Unfunded company
- Navigo - Delhi based, 2024 founded, Unfunded company
- Skynext - Mumbai based, 2020 founded, Unfunded company
- Digital Maker - Peterhead based, 2017 founded, Unfunded company
- Byteport - San Francisco based, 1999 founded, Seed company
- Back Benchers - India based, 2024 founded, Unfunded company
